S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NASDAQ:CRVS

Corvus Pharmaceuticals Earnings Date, Estimates & History

$2.88
-0.03 (-1.03 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.55
Now: $2.88
$2.95
50-Day Range
$2.91
MA: $3.83
$4.77
52-Week Range
$1.01
Now: $2.88
$6.88
Volume1.20 million shs
Average Volume1.12 million shs
Market Capitalization$80.82 million
P/E RatioN/A
Dividend YieldN/A
Beta1.81

Earnings

Corvus Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Corvus Pharmaceuticals (NASDAQ:CRVS) Earnings Estimates

Current Year EPS Consensus Estimate: $-1.45 EPS
Next Year EPS Consensus Estimate: $-1.56 EPS

Corvus Pharmaceuticals (NASDAQ CRVS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
10/29/20209/30/2020($0.24)($0.33)($0.33)N/A
7/30/20206/30/2020($0.28)($0.36)($0.36)Listen
4/30/20203/31/2020($0.40)($0.44)($0.44)Transcript
3/5/202012/31/2019($0.33)($0.38)($0.38)Transcript
10/29/2019Q3 2019($0.42)($0.37)($0.37)Transcript
8/1/2019Q2 2019($0.42)($0.44)($0.44)Transcript
5/9/2019Q1($0.40)($0.40)($0.40)Transcript
3/7/2019Q4($0.4630)($0.36)($0.36)N/A
11/1/2018Q3($0.4760)($0.36)($0.36)N/A
8/2/2018Q2 2018($0.6450)($0.40)($0.40)N/A
5/3/2018Q1 2018($0.7360)($0.63)($0.63)N/A
3/1/2018Q4 2017($0.7650)($0.58)($0.58)N/A
11/2/2017Q3 2017($0.8140)($0.62)($0.62)N/A
8/3/2017Q2 2017($0.76)($0.73)($0.73)N/A
5/4/2017Q1 2017($0.79)($0.79)N/A
3/10/201712/31/2016($0.52)($0.55)($0.55)N/A
11/3/2016Q3 2016($0.45)($0.51)($0.51)N/A
8/4/2016Q2 2016($0.36)($0.43)($0.43)N/A
5/5/2016Q1 2016($5.39)($5.39)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.